Simulation optimization of PSA-threshold based prostate cancer screening policies

被引:17
|
作者
Underwood, Daniel J. [1 ]
Zhang, Jingyu [2 ]
Denton, Brian T. [1 ]
Shah, Nilay D. [3 ]
Inman, Brant A. [4 ]
机构
[1] N Carolina State Univ, Edward P Fitts Dept Ind & Syst Engn, Raleigh, NC 27695 USA
[2] Philips Res N Amer, Briarcliff Manor, NY 10510 USA
[3] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN 55905 USA
[4] Duke Univ, Med Ctr, Div Urol, Durham, NC 27710 USA
基金
美国国家科学基金会;
关键词
Prostate cancer screening; Simulation optimization; Genetic algorithm; Ranking and selection; SATURATION BIOPSY; UNITED-STATES; SELECTION; PROBABILITY; MORTALITY; AUTOPSY; SUBSET; SYSTEM; IMPACT; RISK;
D O I
10.1007/s10729-012-9195-x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
We describe a simulation optimization method to design PSA screening policies based on expected quality adjusted life years (QALYs). Our method integrates a simulation model in a genetic algorithm which uses a probabilistic method for selection of the best policy. We present computational results about the efficiency of our algorithm. The best policy generated by our algorithm is compared to previously recommended screening policies. Using the policies determined by our model, we present evidence that patients should be screened more aggressively but for a shorter length of time than previously published guidelines recommend.
引用
收藏
页码:293 / 309
页数:17
相关论文
共 50 条
  • [41] Dynamic screening for prostate cancer improves AUCs relative to static screening using a single PSA threshold - Results from the duke prostate center
    Freedland, Stephen J.
    Sun, Leon
    Neville, Thomas B.
    Kaminski, David A.
    Falvello, Virginia B.
    Moul, Judd W.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 641 - 642
  • [42] Prostate specific antigen (PSA)-based screening
    Suzuki, Hiroyoshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (09) : 757 - 762
  • [43] Low PSA levels cannot rule out prostate cancer: Prostate cancer detection rates with respect to PSA levels results from a PSA based screening cohort
    Horninger, Wolfgang
    Klocker, Helmut
    Bektic, Jasmin
    Pelzer, Alexandre E.
    Schaefer, Georg
    Brunner, Andrea
    Achleitner, Regina
    Bartsch, Georg
    JOURNAL OF UROLOGY, 2007, 177 (04): : 203 - 204
  • [44] Moving beyond negative campaign for PSA-based screening for prostate cancer
    Ito, Kazuto
    Sekine, Yoshitaka
    Suzuki, Kazuhiro
    Kurosawa, Isao
    CANCER SCIENCE, 2023, 114 : 1536 - 1536
  • [45] Introduction to a seminar on revisiting the value of PSA-based prostate cancer screening
    Carlsson, Sigrid, V
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (02) : 76 - 77
  • [46] Correction to: Unintended consequences of decreased PSA-based prostate cancer screening
    Thomas Ahlering
    Linda My Huynh
    Kamaljot S. Kaler
    Stephen Williams
    Kathryn Osann
    Jean Joseph
    David Lee
    John W. Davis
    Ronney Abaza
    Jihad Kaouk
    Vipul Patel
    Isaac Yi Kim
    James Porter
    Jim C. Hu
    World Journal of Urology, 2020, 38 : 807 - 807
  • [47] Prostate cancer screening and the role of PSA: A UK perspective
    Sooriakumaran, Prasanna
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2021, 88 (01) : 14 - 16
  • [48] Effects of PSA screening on the prostate cancer detection rate
    Berger, AP
    Bektic, J
    Pelzer, A
    Leonhartsberger, N
    Steiner, H
    Bartsch, GC
    Horninger, W
    JOURNAL OF UROLOGY, 2005, 173 (04): : 401 - 402
  • [49] PSA tumor marker for prostate cancer screening in Armenia
    Muradyan, A
    Avagyan, H
    Karabashyan, L
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 358 - 358
  • [50] PSA screening for prostate cancer: The current controversy - a viewpoint
    Barry, MJ
    ANNALS OF ONCOLOGY, 1998, 9 (12) : 1279 - 1282